经过评估,专家小组得出结论,在建议的使用条件下,铁乳蛋白盐作为新型食品是安全的。部分原文报道如下:
Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on iron milk proteinate as a novel food (NF) pursuant to Regulation (EU) 2015/2283 and to address the bioavailability of iron from this source in the co
ntext of Directive 2002/46/EC. The NF is a complex of iron, casein and phosphate, which is produced from iron salts (i.e. ferric chloride or ferric sulfate), sodium caseinate and potassium orthophosphate. The NF is proposed by the applicant to be used as a source of iron, of which the NF co
ntains 2C4%. The applicant intends to market the NF as an ingredient in a number of food categories; in food supplements, in total diet replac
ement for weight co
ntrol and in foods for special medical purposes. The Panel co
nsiders that, taking into account the composition of the NF and the proposed co
nditions of use, co
nsumption of the NF is not nutritio
nally disadvantageous. The studies provided for ADME and bioavailability indicate that iron from the NF is bioavailable. Overall, the evidence indicates that upon ingestion the NF undergoes digestion into small peptides to yield iron-bound caseinophosphopeptides that are normal co
nstituents of the human diet, and that the iron from the NF does not bypass the homeostatic co
ntrol of iron as a nutrient. The Panel co
ncludes that the NF, iron milk proteinate, is safe under the proposed co
nditions of use. The Panel also co
ncludes that the NF is a source from which iron is bioavailable.
本文由食品伙伴网食品资讯中心编辑,供网友参考,有任何疑问,请联系news@www.sqrdapp.com、/span>